Skip to main content
. 2025 Jun 5;16(2):101268. doi: 10.4292/wjgpt.v16.i2.101268

Table 2.

Inflammatory bowel disease -related outcomes, n (%)


Total sample (n = 61)
Active agent (n = 40)
Placebo (n = 21)
P value
Biochemical flare 8 (13.1) 4 (10) 4 (19.0) 0.43
Steroid use or escalation of therapy 8 (13.1) 4 (10) 4 (19.0) 0.43
Biochemical flare or steroid or escalation of therapy 10 (16.4) 5 (12.5) 5 (23.8) 0.29